List view / Grid view
Medical screening is a strategy used to identify the possible presence of an as-yet-undiagnosed disease in individuals without signs or symptoms.
Work with one trusted partner for instruments, software, consumables and service to help keep your laboratory running smoothly. Smooth processes save time, money and maximise your lab’s ROI.
Scientists have identified a molecule that can bind to a lethal subtype of the bacterial Shiga toxin, suppressing its deadly effects.
This whitepaper overviews how high throughput, multi-parametric analysis accelerates antibody discovery workflows.
Single-domain antibodies (sdAb) are small, stable antibodies derived from camelids with a single monomeric variable domain.
27 July 2022 | By Molecular Devices & HeartBeat.bio
Watch this virtual panel discussion to identify ways to overcome common challenges in 3D biology research, regardless of where you are in your journey.
The researchers found predictive protein patterns and links of maternal autoantibody–related autism spectrum disorder in the blood of expecting mothers.
A new single-cell nanoparticle targeting-sequencing approach can measure the cellular uptake of lipid nanoparticles carrying mRNA therapies.
Find western blot application protocols and troubleshooting tips for detecting proteins in this handbook.
Researchers from the US have identified several new small molecules that can induce mitophagy in leukaemia cells.
4 July 2022 | By Eurofins Discovery
In this on-demand webinar, an assay strategy to assess transport-mediated drug interactions that complies with regulations is examined.
This infographic will explore Mycoplasma contamination in cell cultures and the best technologies for detection.
30 June 2022 | By Brooks Automation
Watch this on-demand webinar to learn how collaborative robots are improving accuracy and efficiency in today’s laboratories.
Scientists have synthesised a new molecule that could kill a broad spectrum of hard-to-treat cancers, including triple-negative breast cancer, by exploiting a weakness in cells not previously targeted by other drugs.
The combination of two drugs was more effective in eradicating leukaemia cells in zebrafish and human disease than using a single drug.
Here Bio-Rad presents the generation of specific anti-CAR T-cell antibodies to show how CAR T-cell analysis benefits from our modular antibody assembly technology using SpyTag-SpyCatcher protein ligation.
